CDMO News
Nikon CeLL Innovation Signs Licensing Deal with RoosterBio for Stem Cell Therapeutics
Nikon CeLL innovation Co., Ltd. (NCLi), a subsidiary of Nikon Corporation, has entered into a strategic licensing agreement with RoosterBio, Inc., a US-based stem cell technology company. The agreement aims to provide Japan’s biopharma sector with a comprehensive solution for the
16 April 2025